
NASDAQ:KINS
This summary was created by AI, based on 7 opinions in the last 12 months.
Kingstone Companies Inc (KINS-Q) has received strong endorsements from analysts, particularly from Michael O'Reilly. The company is positioned as a leading property and casualty insurance provider in New York, recently reporting record-high net income and experiencing a significant reduction in homeowner claims. Its financials exhibit a solid return on equity of around 31-33% across various reports, suggesting robust financial health. Analysts have noted the company's improving cash reserves and strategic moves, including recent reinsurance agreements that enhance its coverage capabilities. Recommendations to adjust stop-loss levels indicate confidence in the stock's growth potential, with several targets suggesting significant upside from current levels.
Kingstone Companies Inc is a American stock, trading under the symbol KINS (previously KINS-Q on Stockchase) on the NASDAQ (KINS). It is usually referred to as NASDAQ:KINS or KINS
In the last year, 7 stock analysts issued a Buy, Sell, or Hold rating on KINS (previously KINS-Q on Stockchase). 7 analysts recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is TOP PICK. Read the latest stock experts' ratings for Kingstone Companies Inc.
Kingstone Companies Inc was recommended as a Top Pick by The Panic-Proof Portfolio (Stockchase Research) on 2026-09-01. Read the latest stock experts ratings for Kingstone Companies Inc.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Kingstone Companies Inc.
Kingstone Companies Inc is followed by 9 investors on Stockchase and is a trending stock that is worth watching.
On 2026-09-03, Kingstone Companies Inc (KINS) stock closed at a price of $20.22.
We reiterate this property and casualty insurance provider as a TOP PICK. Recently reported net income hit an all time record high. Homeowner claims were down 34%. It trades at 8x earnings, 2.2x book and supports a 31% ROE. Quarterly cash reserves are growing, while shares are bought back. We continue to recommend a stop at $17, looking to achieve $24 -- upside potential of 21%. Yield 1.0%
(Analysts’ price target is $23.99)